Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,767,364,935
-
Number of holders
-
2,023
-
Total 13F shares, excl. options
-
1,025,594,398
-
Shares change
-
-16,499,320
-
Total reported value, excl. options
-
$82,642,729,287
-
Value change
-
-$1,357,273,013
-
Put/Call ratio
-
119%
-
Number of buys
-
876
-
Number of sells
-
1,018
-
Price
-
$80.59
Institutional Holders of AbbVie Inc. - Common Stock (ABBV) as of Q1 2019
2,224 filings reported holding ABBV - AbbVie Inc. - Common Stock as of 31 Mar 2019.
AbbVie Inc. - Common Stock (ABBV) had 2,023 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,025,594,398 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Capital International Investors, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Orbis Allan Gray Ltd, Capital World Investors, and Bank of New York Mellon Corp.
This table shows the top 2,023 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.